Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Pacific Biosciences of California    P09

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
01/15/2018 01/16/2018 01/17/2018 01/18/2018 01/19/2018 Date
2.18(c) 2.1(c) 2.16(c) 2.18(c) 2.12(c) Last
0 0 8 0 860 Volume
-2.68% -3.67% +2.86% +0.93% -2.75% Change
More quotes
Financials ($)
Sales 2017 90,3 M
EBIT 2017 -91,4 M
Net income 2017 -94,2 M
Debt 2017 0,60 M
Yield 2017 -
Sales 2018 113 M
EBIT 2018 -79,0 M
Net income 2018 -79,2 M
Finance 2018 0,27 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 3,48x
EV / Sales2018 2,78x
Capitalization 314 M
More Financials
Company
Pacific Biosciences of California, Inc. engages in the research, development and manufacture of sequencing systems for genetic analysis.It operates through the following geographical segments: North America, Europe, and Asia.It offers deoxyribonucleic acid sequencing, third generation sequencing... 
More about the company
Surperformance© ratings of Pacific Biosciences of Cal
Trading Rating : Investor Rating :
More Ratings
Latest news on PACIFIC BIOSCIENCES OF CAL
2017 PACIFIC BIOSCIENCES OF CALIFORNIA : DNA sequencer maintenance
2017 PACIFIC BIOSCIENCES OF CALIFORNIA : Appoints Kathy Ordoez as Chief Commercial Of..
2017 PACIFIC BIOSCIENCES OF CALIFORNIA : reports 3Q loss
2017 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Change in Directors or Principal Officers..
2017 PACIFIC BIOSCIENCES OF CALIFORNIA : Management's Discussion and Analysis of Fina..
2017 Pacific Biosciences Appoints Kathy Ordoñez as Chief Commercial Officer
2017 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Results of Operations and Financial Condi..
2017 Pacific Biosciences of California, Inc. Announces Third Quarter 2017 Financia..
2017 Pacific Biosciences of California, Inc. Third Quarter 2017 Financial Results ..
2017 Recent Projects Highlight Success of SMRT Sequencing for Characterizing Struc..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
01/16 Siemens' Healthineers in pre-IPO cost-cutting drive
01/09 BOSTON SCIENTIFIC : Health Care Up On Earnings Optimism -- Health Care Roundup
01/03 Akzo Nobel appoints Arcadis's Vree as CFO of chemicals business
2017 ROYAL PHILIPS : Philips Buys VitalHealth for Undisclosed Sum
2017 SAFRA CATZ : Oracle's Safra Catz among two new members named to Disney board
More sector news : Advanced Medical Equipment & Technology - NEC
Chart PACIFIC BIOSCIENCES OF CAL
Duration : Period :
Pacific Biosciences of Cal Technical Analysis Chart | P09 | US69404D1081 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 5,03 $
Spread / Average Target 86%
EPS Revisions
Managers
NameTitle
Michael W. Hunkapiller Executive Chairman, President & CEO
Susan K. Barnes CFO, Principal Accounting Officer & Executive VP
Stephen W. Turner Chief Technical Officer & Vice President
James Michael Phillips Senior Vice President-Research & Development
Jonas Korlach Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
PACIFIC BIOSCIENCES OF CALIFORNIA-1.62%314
THERMO FISHER SCIENTIFIC11.38%84 729
DANAHER7.29%69 380
INTUITIVE SURGICAL18.13%48 413
ROYAL PHILIPS4.11%37 878
BOSTON SCIENTIFIC CORPORATION9.92%37 626